Tissue distribution of CD94 transcripts
. | Age, y . | Sex . | Tissue . | Diagnosis . | CD94 . |
|---|---|---|---|---|---|
| CD34 progenitors and thymus | |||||
| 1 | 0* | M | CD34+Lin+UC progenitors | Healthy newborn | Neg |
| 2 | 0* | M | CD34+Lin-UC progenitors | Same case above | Neg |
| 3 | 0* | F | CD34+Lin+UC progenitors | Healthy newborn | Neg |
| 4 | 0* | F | CD34+Lin-UC progenitors | Same case above | Neg |
| 5 | 1* | F | Thymus | Premature infant (GA, 29 wk) | 1A |
| 6 | 1* | F | Thymus | Premature infant (GA, 37 wk) | 1A |
| 7 | 1* | M | Thymus | Premature infant (GA, 27 wk) | 1A |
| 8 | 1* | M | Thymus | Premature infant (GA, 27 wk) | 1A |
| 9 | 40 | F | Thymus | MG with LH | 1A |
| 10 | 17 | F | Thymus | MG with LH | 1A>>1B |
| Peripheral tissues | |||||
| 1 | 44 | M | Spleen | Cirrhosis with hypersplenism and pancytopenia | 1A |
| 2 | 32 | F | Endometrium | Reactive endometrium | 1B |
| 3 | 75 | M | Spleen | Gastric cancer without splenic involvement | 1B |
| 4 | 45 | F | Endometrium | Reactive endometrium | 1B>>1A |
| 5 | 74 | M | Spleen | Cirrhosis with splenomegaly | 1B>>1A |
| 6 | 65 | M | Tonsil | Chronic tonsillitis | 1B>>1A |
| 7 | 43 | M | PB | Healthy volunteer | 1B>>1A |
| 8 | 24 | M | PB | Healthy volunteer | 1B>>1A |
| 9 | 28 | F | PB | Healthy volunteer | 1B>>1A |
| 10 | 27 | F | PB | Healthy volunteer | 1B>>1A |
| ENNLs | |||||
| 1 | 60 | M | Nasal cavity | ENNL | Neg |
| 2 | 65 | M | Nasal cavity | ENNL | Neg |
| 3 | 45 | F | Nasal cavity | ENNL | Neg |
| 4 | 61 | M | Nasal cavity | ENNL | 1A |
| 5 | 42 | M | Nasal cavity | ENNL | 1B>>1A |
| 6 | 62 | M | Nasal cavity | ENNL | 1B>>1A |
| 7 | 55 | M | Nasal cavity | ENNL | 1B>>1A |
| 8 | 39 | F | Nasal cavity | ENNL | 1B>>1A |
| 9 | 69 | M | Nasal cavity | ENNL | 1B>>1A |
| 10 | 38 | M | Nasal cavity | ENNL | 1B>>1A |
. | Age, y . | Sex . | Tissue . | Diagnosis . | CD94 . |
|---|---|---|---|---|---|
| CD34 progenitors and thymus | |||||
| 1 | 0* | M | CD34+Lin+UC progenitors | Healthy newborn | Neg |
| 2 | 0* | M | CD34+Lin-UC progenitors | Same case above | Neg |
| 3 | 0* | F | CD34+Lin+UC progenitors | Healthy newborn | Neg |
| 4 | 0* | F | CD34+Lin-UC progenitors | Same case above | Neg |
| 5 | 1* | F | Thymus | Premature infant (GA, 29 wk) | 1A |
| 6 | 1* | F | Thymus | Premature infant (GA, 37 wk) | 1A |
| 7 | 1* | M | Thymus | Premature infant (GA, 27 wk) | 1A |
| 8 | 1* | M | Thymus | Premature infant (GA, 27 wk) | 1A |
| 9 | 40 | F | Thymus | MG with LH | 1A |
| 10 | 17 | F | Thymus | MG with LH | 1A>>1B |
| Peripheral tissues | |||||
| 1 | 44 | M | Spleen | Cirrhosis with hypersplenism and pancytopenia | 1A |
| 2 | 32 | F | Endometrium | Reactive endometrium | 1B |
| 3 | 75 | M | Spleen | Gastric cancer without splenic involvement | 1B |
| 4 | 45 | F | Endometrium | Reactive endometrium | 1B>>1A |
| 5 | 74 | M | Spleen | Cirrhosis with splenomegaly | 1B>>1A |
| 6 | 65 | M | Tonsil | Chronic tonsillitis | 1B>>1A |
| 7 | 43 | M | PB | Healthy volunteer | 1B>>1A |
| 8 | 24 | M | PB | Healthy volunteer | 1B>>1A |
| 9 | 28 | F | PB | Healthy volunteer | 1B>>1A |
| 10 | 27 | F | PB | Healthy volunteer | 1B>>1A |
| ENNLs | |||||
| 1 | 60 | M | Nasal cavity | ENNL | Neg |
| 2 | 65 | M | Nasal cavity | ENNL | Neg |
| 3 | 45 | F | Nasal cavity | ENNL | Neg |
| 4 | 61 | M | Nasal cavity | ENNL | 1A |
| 5 | 42 | M | Nasal cavity | ENNL | 1B>>1A |
| 6 | 62 | M | Nasal cavity | ENNL | 1B>>1A |
| 7 | 55 | M | Nasal cavity | ENNL | 1B>>1A |
| 8 | 39 | F | Nasal cavity | ENNL | 1B>>1A |
| 9 | 69 | M | Nasal cavity | ENNL | 1B>>1A |
| 10 | 38 | M | Nasal cavity | ENNL | 1B>>1A |
UC indicates umbilical cord; Neg, negative; GA, gestational age; MG with LH, myasthenia gravis with lymphoid hyperplasia; PB, peripheral blood; ENNL, extranodal nasal-type NK/T-cell lymphoma.
Age in days